Conversio Health
- Company typePrivate
- Founded2012
- HeadquartersHouston, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
Conversio Health firmographics
Firmographics- Name
- Conversio Health
- Legal name
- Integrated Health Concepts, Inc.
- Website
- https://conversiohealth.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Conversio Health industry classification
Industry- Product category
- Respiratory Disease Management
- NAICS
- Offices of Other Health Practitioners (6213)
- SIC
- Services-Home Health Care Services (8082), Services-Misc Health & Allied Services, Nec (8090), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Home Respiratory & Sleep Therapy Providers (DME-Integrated) (HLAFAEAF)
- akta.pro secondary industries
- Pulmonary Rehabilitation Programs (HLAFAFAK), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM), Asthma & Allergy-Related Pulmonary Care (HLAKANAD), Membership/Subscription Concierge Virtual Care (HLALAAAH)
Keywords
Where Conversio Health is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Conversio Health business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- All-inclusive Monthly COPD/Asthma Program Fee: Monthly program fees covering full disease management including COPD/Asthma medications, traditional nebulizers, Conversio smart devices, virtual pulmonary rehab, Conversio Connect app, and high-touch pharmacotherapy management. Charged only for enrolled and engaged members with no minimum patient volume required. Typical value-based arrangement structure.
- Pay for Performance Incentives: Performance incentives/penalties based upon performance against predefined quality and satisfaction measures, integrated into value-based arrangements with health plan and provider partners.
- Full Risk Arrangement Savings: Up to 100% of fees put at risk to guarantee outcomes/ROI with shared savings and bonus opportunity to align incentives with partner outcomes.
- Pharmacy Fulfillment Services: Specialized mail service pharmacy providing custom nebulizer medications and respiratory supplies delivered directly to patient homes, covered under insurance plans.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | All-inclusive Monthly COPD/Asthma Program Fee |
| Subscription | Monthly | Patient $0 Copay Program |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels8 records
Conversio Health product offering
Product offeringCore offering
Conversio Health provides an integrated value-based chronic respiratory disease management program for COPD and asthma, combining custom-compounded nebulizer medications, proprietary Bluetooth-enabled smart devices (SmartNeb portable nebulizer and SmartCap inhaler with spirometer), a 12-week Inspire virtual pulmonary rehabilitation program, the Conversio Connect mobile app, and an AI-driven predictive analytics platform. Services are delivered to enrolled members of Medicare Advantage, Managed Medicaid, and at-risk provider partners on an all-inclusive monthly per-member fee with optional pay-for-performance and full-risk arrangements, supported by clinical pharmacists, respiratory therapists, and health coaches.
Product overview
Conversio Health offers a comprehensive, integrated respiratory disease management platform combining custom nebulizer medications, Bluetooth-enabled smart devices (SmartNeb portable nebulizer and SmartCap 3-in-1 inhaler with spirometer), the Inspire™ Virtual Pulmonary Rehabilitation Program, and the Conversio Connect mobile app. The platform is powered by an AI predictive analytics engine that monitors patient data in real time and identifies those at high risk of hospitalization. Clinical pharmacists, respiratory therapists, and health coaches provide high-touch pharmacotherapy management and ongoing patient engagement. The company delivers value-based care programs primarily to Medicare Advantage Plans, Managed Medicaid Plans, and At-Risk Provider Groups.
Differentiator
Problem solved
Functional benefit
Brands
- SmartNeb: Portable Bluetooth-enabled smart nebulizer device that captures medication adherence in real time.
- SmartCap
- Inspire
- Conversio Connect
Products and services
- SmartNeb Portable Nebulizer
Quantifiable outcome
- 85% of patients who use inhalers make errors when taking their medications; Conversio's custom nebulizer medications improve drug delivery and lung penetration
- +6 more outcomes
Companies that use Conversio Health
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Conversio Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
Conversio Health partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- America's Physician GroupscoreConversio Health participated in the America's Physician Groups Spring Conference 2025 in San Diego (Booth 408), presenting its value-based care COPD and asthma chronic condition management program to provider organizations and health plan partners seeking to improve patient outcomes and reduce total cost of care.
- Accountable for Health (A4H)coreConversio Health partnered with Accountable for Health to showcase its COPD and asthma disease management program through case studies. The partnership demonstrates how Conversio's virtual pulmonary rehab, breathing medications, remote monitoring, and expert coaching help COPD patients regain mobility and quality of life.
- Congressman Gabe AmominorConversio Health Chief Growth Officer Christopher Dooley met with Congressman Gabe Amo at the Accountable for Health Value Week Conference to advocate for continued innovation, expansion, and funding for value-based care models.
- American Lung AssociationminorConversio Health provides educational resources from the American Lung Association on its patient portal, connecting patients with additional respiratory health information and support.
- COPD FoundationminorConversio Health provides educational resources from the COPD Foundation to patients, supporting respiratory disease awareness and patient education.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Conversio Health competitors and assessment
Company assessmentDirect peers
- Lincare (Linde): National home respiratory therapy provider (oxygen, nebulizers, sleep) owned by Linde. Most direct comparison on home respiratory delivery to chronic respiratory patients, including payer and provider relationships across MA and Medicaid populations.
- Apria Healthcare (Owens & Minor): One of the largest US home respiratory DME providers, offering nebulizers, oxygen therapy, and sleep therapy equipment. Directly comparable to Conversio on the home respiratory/DME delivery leg, though Apria operates primarily under fee-for-service rather than value-based contracting.
- AdaptHealth: Public home medical equipment company with a large respiratory DME business serving patients with COPD, asthma, and sleep disorders. Competes with Conversio on home delivery of nebulizers and related supplies, with growing interest in value-based care partnerships.
- Propeller Health (ResMed): Pioneer in Bluetooth-enabled inhaler sensors and digital respiratory management; acquired by ResMed in 2019. Closest comparable to Conversio's SmartCap and AI adherence layer, now embedded inside a large sleep/respiratory device incumbent.
Broad incumbents
- ResMed: Global leader in sleep and respiratory care devices (CPAP, ventilators) and owner of Propeller Health. Broad incumbent in connected respiratory care; competes with Conversio via devices and digital adherence tooling, though at much larger scale and broader scope.
- Philips Respironics: Major respiratory and sleep therapy device manufacturer (ventilators, CPAP, nebulizer platforms). Broad incumbent supplying respiratory hardware globally; competes indirectly as a device alternative to Conversio's SmartNeb/SmartCap ecosystem.
Emerging players
- Wellinks: Virtual-first COPD management company combining connected devices, pulmonary rehabilitation, and care coaching. Closest emerging-stage competitor to Conversio's Inspire virtual pulmonary rehab and B2B2C payer motion.
- NuvoAir: Digital respiratory health company offering remote spirometry, virtual pulmonary rehab, and chronic respiratory care management across the US and Europe. Comparable as a digitally enabled respiratory care provider competing for similar payer and at-risk provider contracts.
Others
- AstraZeneca: Major respiratory pharmaceutical company (Symbicort, Breztri, Fasenra, Saphnelo). Adjacent comparator to Conversio's custom nebulizer franchise and a relevant counterparty if Conversio expands into combination respiratory biologics or partnership-driven distribution.
- GSK (GlaxoSmithKline): Global pharmaceutical leader with a major respiratory portfolio (Trelegy Ellipta, Advair, Nucala). Adjacent comparator on the medication leg of respiratory care; potential partner or competitor depending on whether Conversio's custom nebulizer formulations substitute or complement GSK inhaler products.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Conversio Health social profiles
Digital presenceConversio Health compliance and trust
Trust signalCompliance4 records
Conversio Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Conversio Health leadership team
Management profileNumber of profiles
Profiles5 records
Conversio Health funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Conversio Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Conversio Health
What does Conversio Health do?
Conversio Health provides an integrated value-based chronic respiratory disease management program for COPD and asthma, combining custom-compounded nebulizer medications, proprietary Bluetooth-enabled smart devices (SmartNeb portable nebulizer and SmartCap inhaler with spirometer), a 12-week Inspire virtual pulmonary rehabilitation program, the Conversio Connect mobile app, and an AI-driven predictive analytics platform. Services are delivered to enrolled members of Medicare Advantage, Managed Medicaid, and at-risk provider partners on an all-inclusive monthly per-member fee with optional pay-for-performance and full-risk arrangements, supported by clinical pharmacists, respiratory therapists, and health coaches.
Is Conversio Health a public or private company?
Conversio Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Conversio Health founded?
Conversio Health was founded in 2012. It employs 51 to 100 people.
Where is Conversio Health based?
Conversio Health is headquartered in Houston, United States, in the North America region.
How does Conversio Health make money?
Four revenue lines are on record. All-inclusive Monthly COPD/Asthma Program Fee is the primary driver. The others are pay for Performance Incentives, full Risk Arrangement Savings and pharmacy Fulfillment Services.
Who are Conversio Health's main competitors?
Direct peers on record are Lincare (Linde), Apria Healthcare (Owens & Minor), AdaptHealth and Propeller Health (ResMed). Broad incumbents are ResMed and Philips Respironics. Emerging players are Wellinks and NuvoAir. Others are AstraZeneca and GSK (GlaxoSmithKline).
Does Conversio Health have an API?
No public API is recorded for Conversio Health.
What industry is Conversio Health in?
Conversio Health's product category is Respiratory Disease Management. Its primary akta.pro industry code is HLAFAEAF, Home Respiratory & Sleep Therapy Providers (DME-Integrated), with a secondary code of HLAFAFAK, Pulmonary Rehabilitation Programs. Its NAICS code is 6213 and its SIC code is 8082.